[New Year's Message] Huons "Achieving Group Sales of 1 Trillion Won, Global Leap"

Yoon Sung-tae, Chairman of Huons Group, is delivering the New Year's address at the online opening ceremony. (Photo by Huons Group)

[Asia Economy Reporter Lee Chun-hee] Huons Group announced its New Year's resolution to "achieve group sales of 1 trillion KRW and confirm the possibility of advancing as a global pharmaceutical company."

Huons Global announced on the 3rd that it held the group's online opening ceremony on the 2nd. The ceremony was attended by about 1,800 executives and employees, including Yoon Sung-tae, Chairman of Huons Group, and Song Soo-young, CEO of Huons Global. The event proceeded in the order of last year's top 10 group news, Huons Group's mid- to long-term strategy, Chairman Yoon Sung-tae's New Year's address, and encouragement messages.

To make a strong leap toward the corporate vision of becoming a "Global Total Healthcare Group," Huons Group presented the management policy for this year as 'H.O.P.E (Harmony: maximizing synergy, Overcome: overcoming crises, Pinpoint: selection and concentration, Efficiency: management efficiency).' Through this, the group plans to create synergy in various fields such as pharmaceuticals, aesthetics, health functional foods, and botulinum toxin, aiming to achieve stable growth and record-breaking performance. Additionally, the strategy focuses on concentrating core capabilities on businesses and research & development (R&D) that align with the mid- to long-term vision for future growth, while emphasizing management efficiency for sustainable growth.

CEO Song stated, "We have set the combination of various business areas related to health and beauty, including pharmaceuticals, medical devices, health functional foods, containers, and puffs, as a mid- to long-term policy," adding that through this, "we will achieve group sales of 1 trillion KRW, confirm the possibility of advancing as a global pharmaceutical company, and secure momentum for a quantum jump by improving operating profit margins." He also added, "We will establish a management system suitable for the expansion of corporate scale and business through overall management improvements."

Chairman Yoon said in his New Year's address, "Thanks to all Huons Group family companies fulfilling their duties in their respective positions despite difficult conditions last year, we achieved results exceeding our goals," and added, "Although a challenging management environment is expected this year, we will overcome crises with the resilience we have built and prepare for a sustainable and vigorous leap forward." He also mentioned, "This year, we will achieve future sustainable growth by addressing important pending projects such as strengthening entry into the U.S. market, expanding business in Japan, increasing development of improved new drugs, obtaining DMF approval for heparin raw materials, and acquiring individual certification approval for health functional foods."